Clinical and anamnestic risk factors for the development of uterine leiomyoma in women of reproductive age: A case control study
- Authors: Malyshkina D.A.1,2, Sotnikova N.Y.1, Voronin D.N.1, Kalinina A.E.2, Godunova E.M.2, Golubeva M.V.2, Rumyanceva E.V.2
-
Affiliations:
- Gorodkov Ivanovo Scientific Research Institute of Maternity and Childhood
- Ivanovo State Medical Academy
- Issue: Vol 25, No 2 (2023)
- Pages: 170-176
- Section: ORIGINAL ARTICLE
- URL: https://ogarev-online.ru/2079-5831/article/view/134140
- DOI: https://doi.org/10.26442/20795696.2023.2.202209
- ID: 134140
Cite item
Full Text
Abstract
Aim. To identify risk factors for uterine leiomyoma (ULM) in women of reproductive age based on the study of clinical and medical history features in various tumor types.
Materials and methods. The study included 82 women of reproductive age with symptomatic ULM (the main group) and 47 somatically healthy women of reproductive age without proliferative gynecological diseases who underwent elective treatment at the Gorodkov Ivanovo Research Institute of Motherhood and Childhood (Director is professor AI Malyshkina, MD, Ph.D.). The study patients underwent general clinical examinations, ultrasound examination of the pelvic organs, histological examination of endometrial biopsy specimens, and myomatous nodes in women of the main group.
Results. The following risk factors and clinical and history features were identified in women with uterine fibroids: late reproductive age (p=0.000), unregistered marriage (p=0.026), employment (p=0.006), history of profuse and painful menstruation (p=0.000 and p=0.000, respectively), inflammatory diseases of the respiratory system (p=0.003), pain syndrome and profuse menstruation (p=0.000 and p=0.000, respectively), endometrial hyperplasia without atypia, and chronic endometritis according to histological examination (p=0.000 and p=0.000, respectively). When comparing the subgroups "Ki67+" and "Ki67-", we obtained the following clinical and history features in women with proliferating uterine fibroids: varicose disease of the lower extremities (p=0.035); and when comparing the subgroups "with secondary changes" and "without secondary changes", we found a higher rate of pain (p=0.038) in women with secondary changes in the myomatous node, as well as a tendency to a higher rate of painful menstruation (p=0.093) and endometrial hyperplasia (p=0.093).
Conclusion. Risk factors for ULM in women of reproductive age can be divided into modifiable ones, which include social disadvantage (unregistered marriage, hard physical work), inflammatory factor (inflammatory diseases of the respiratory system) and unmodifiable (late reproductive age). Clinical and history features of women with Ki67+ ULM compared to women with Ki67- ULM include more frequent use of barrier contraception, high prevalence of varicose vein disease of the lower extremities, and surgical interventions on the pelvic organs. Also, according to histological examination, women with ULM with secondary changes in the myomatous node, compared to women with ULM without secondary changes in the myomatous node, have a higher prevalence of painful menstruation, pain syndrome, and concomitant endometrial hyperplasia.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Darya A. Malyshkina
Gorodkov Ivanovo Scientific Research Institute of Maternity and Childhood; Ivanovo State Medical Academy
Author for correspondence.
Email: nidsumi@mail.ru
ORCID iD: 0000-0002-1200-3570
Graduate Student
Russian Federation, Ivanovo; IvanovoNataliya Yu. Sotnikova
Gorodkov Ivanovo Scientific Research Institute of Maternity and Childhood
Email: niimid.immune@mail.ru
ORCID iD: 0000-0002-0608-0692
D. Sci. (Med.), Prof.
Russian Federation, IvanovoDmitriy N. Voronin
Gorodkov Ivanovo Scientific Research Institute of Maternity and Childhood
Email: arina.kalinina2000@gmail.com
ORCID iD: 0000-0003-2836-8694
Cand. Sci. (Med.)
Russian Federation, IvanovoArina E. Kalinina
Ivanovo State Medical Academy
Email: arina.kalinina2000@gmail.com
ORCID iD: 0000-0002-7114-7283
Student
Russian Federation, IvanovoElizaveta M. Godunova
Ivanovo State Medical Academy
Email: godunova2000@yandex.ru
ORCID iD: 0000-0003-0404-4433
Student
Russian Federation, IvanovoMaria V. Golubeva
Ivanovo State Medical Academy
Email: golubevamaria66@gmail.com
ORCID iD: 0000-0003-1319-6623
Student
Russian Federation, IvanovoElizaveta V. Rumyanceva
Ivanovo State Medical Academy
Email: Lizavetaruss@mail.ru
ORCID iD: 0000-0002-2768-5391
Student
Russian Federation, IvanovoReferences
- Аганезова Н.В., Аганезов С.С., Шило М.М. Миома матки: современные практические аспекты заболевания. Проблемы репродукции. 2022;28(4):97-105 [Aganezova NV, Aganezov SS, ShiloMM. Uterine fibroids: modern practical aspects of the disease. Russian Journal of Human Reproduction. 2022;28(4):97-105 (in Russian)]. doi: 10.17116/repro20222804197
- Тихомиров А.Л. Миома, патогенетическое обоснование органосохраняющего лечения. Под ред. А.Л. Тихомирова. М., 2013 [Tikhomirov AL. Mioma, patogeneticheskoie obosnovaniie organosokhraniaiushchego lecheniya. Pod red. AL Tikhomirova. Moscow, 2013 [(in Russian)].
- Адамян Л.В., Андреева Е.Н., Артымук Н.В., и др. Миома матки. Клинические рекомендации. М.: Научный центр акушерства, гинекологии и перинатологии им. акад. В.И. Кулакова, 2020 [Adamyan LV, Andreeva EN, Artymuk NV, et al. Mioma matki. Klinicheskiie rekomendatsii. Moscow: Nauchnyy tsentr akusherstva, ginekologii i perinatologii im. akad. VI Kulakova, 2020 (in Russian)].
- Toprani SM, Kelkar Mane V. Role of DNA damage and repair mechanisms in uterine fibroid/leiomyomas: a review. Biol Reprod. 2021;104(1):58-70. doi: 10.1093/biolre/ioaa157
- Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020;149(1):3-9. doi: 10.1002/ijgo.13102
- Marsh EE, Al-Hendy A, Kappus D, et al. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women. J Womens Health (Larchmt). 2018;27(11):1359-67. doi: 10.1089/jwh.2018.7076
- Freytag D, Günther V, Maass N, Alkatout I. Uterine Fibroids and Infertility. Diagnostics (Basel). 2021;11(8):1455. doi: 10.3390/diagnostics11081455
- Kossaï M, Penault-Llorca F. Role of Hormones in Common Benign Uterine Lesions: Endometrial Polyps, Leiomyomas, and Adenomyosis. Adv Exp Med Biol. 2020;1242:37-58. doi: 10.1007/978-3-030-38474-6_3
- Ghosh S, Naftalin J, Imrie R, Hoo WL. Natural History of Uterine Fibroids: A Radiological Perspective. Curr Obstet Gynecol Rep. 2018;7(3):117-21. doi: 10.1007/s13669-018-0243-5
- Алтухова О.Б., Радзинский В.Е., Сиротина С.С. Полиморфизм генов интерлейкинов и риск развития миомы матки. Акушерство и гинекология. 2022;7:81-7 [Altukhova OB, Radzinsky VE, Sirotina SS, et al. Interleukin gene polymorphism and risk of uterine fibroids. Akusherstvo i ginekologiia. 2022;7:81-7 (in Russian)]. doi: 10.18565/aig.2022.7.81-87
- Mára M, Horák P, Kuzel D. Genetic factors in etiology of uterine fibroids. Ceska Gynekol. 2012;77(1):58-60.
- Lin CY, Wang CM, Chen ML, Hwang BF. The effects of exposure to air pollution on the development of uterine fibroids. Int J Hyg Environ Health. 2019;222(3):549-55. doi: 10.1016/j.ijheh.2019.02.004
- Анциферова Ю.С., Воронин Д.Н., Сотникова Н.Ю., и др. Молекулярные механизмы регуляции роста лейомиомы матки. Журнал акушерства и женских болезней. 2017;66(4):7-13 [Antsiferova YuS, Voronin VN, Sotnikova NYu, et al. Molecular mechanisms of regulation of uterine leiomyoma growth. Journal of Obstetrics and Women’s Diseases. 2017;66(4):7-13 (in Russian)]. doi: 10.17816/JOWD6647-13
- Tinelli A, Vinciguerra M, Malvasi A, et al. Uterine Fibroids and Diet. Int J Environ Res Public Health. 2021;18(3):1066. doi: 10.3390/ijerph18031066
- Gao M, Wang H. Frequent milk and soybean consumption are high risks for uterine leiomyoma: A prospective cohort study. Medicine (Baltimore). 2018;97(41):e12009. doi: 10.1097/MD.0000000000012009
- Takala H, Yang Q, El Razek AMA, et al. Alcohol Consumption and Risk of Uterine Fibroids. Curr Mol Med. 2020;20(4):247-58. doi: 10.2174/1566524019666191014170912
- Kwas K, Nowakowska A, Fornalczyk A, et al. Impact of Contraception on Uterine Fibroids. Medicina (Kaunas). 2021;57(7):717. doi: 10.3390/medicina57070717
- Малышкина А.И., Сотникова Н.Ю., Анциферова Ю.С., Красильникова А.К. Иммунные механизмы быстрого роста миомы матки. Монография. Иваново: Иваново, 2010 [Malyshkina AI, Sotnikova NIu, Antsiferova IuS, Krasil'nikova AK. Immunnyie mekhanizmy bystrogo rosta miomy matki. Monografiia. Ivanovo: Ivanovo, 2010 (in Russian)].
- Sun K, Xie Y, Zhao N, Li Z. A case-control study of the relationship between visceral fat and development of uterine fibroids. Exp Ther Med. 2019;18(1):404-10. doi: 10.3892/etm.2019.7575
- Keaton JM, Jasper EA, Hellwege JN, et al. Evidence that geographic variation in genetic ancestry associates with uterine fibroids. Hum Genet. 2021;140(10):1433-40. doi: 10.1007/s00439-021-02322-y
- Al-Hendy A, Myers ER, Stewart E. Uterine Fibroids: Burden and Unmet Medical Need. Semin Reprod Med. 2017;35(6):473-80. doi: 10.1055/s-0037-1607264
- Тоноян Н.М., Козаченко И.Ф., Франкевич В.Е., и др. Рецидивы миомы матки. Современный взгляд на проблемы диагностики, лечения и прогнозирования. Акушерство и гинекология. 2019;3:32-8 [Tonoian NM, Kozachenko IF, Frankevich VIe, et al. Retsidivy miomy matki. Sovremennyi vzgliad na problemy diagnostiki, lecheniia i prognozirovaniia. Akusherstvo i ginekologiia. 2019;3:32-8 (in Russian)].
- Феофилова М.А., Павлов О.Г., Геймерлинг В.Э. Влияние образа жизни и производственных вредностей на развитие миомы матки. Проблемы социальной гигиены, здравоохранения и истории медицины. 2018;26(6):406-10 [Feofilova MA, Pavlov OG, Geimerling VE. The effect of life-style and occupational hazards on development of hysteromyoma. Problemy sotsial'noi gigiieny, zdravookhraneniia i istorii meditsiny. 2018;26(6):406-10 (in Russian)].
- Islam MS, Ciavattini A, Petraglia F, et al. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018;24(1):59-85.
- Коган Е.А., Аскольская С.И., Бурыкина П.Н., и др. Морфофункциональное состояние эндометрия у больных миомой матки репродуктивного возраста. Акушерство и гинекология. 2013;8:46-51 [Kogan YeA, Askol'skaya SI, Burykina PN, et al. Morfofunktsional'noie sostoianiie endometriia u bol'nykh miomoi matki reproduktivnogo vozrasta. Akusherstvo i ginekologiia. 2013;8:46-51 (in Russian)].
- Козаченко И.Ф., Файзуллина Н.М., Щеголев А.И., Адамян Л.В. Рецептивность эндометрия у больных доброкачественными заболеваниями матки в сочетании с бесплодием до и после оперативного лечения. Акушерство и гинекология. 2020;11:147-58 [Kozachenko IF, Fayzullina NM, Shchegolev AI, Adamyan LV. Retseptivnost' endometriia u bol'nykh dobrokachestvennymi zabolevaniiami matki v sochetanii s besplodiiem do i posle operativnogo lecheniia. Akusherstvo i ginekologiia. 2020;11:147-58 (in Russian)].
Supplementary files
